HCV ADVOCATE WEEKLY NEWS REVIEW

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW

A Review of HCV, HBV and HIV/HCV Coinfection Related News and HighlightsWeek Ending: March 6, 2010

This Issue:

Ethnic Media Support Hepatitis C Awareness Campaign City College of San Francisco Students Train to Handle Ex-Inmates' Health Issues IL28B Gene Variation Predicts Response to Hepatitis C Treatment: Will It Change Treatment of Co-Infection? Two New Bills in Colorado House Aim to Prevent Repeat of Hepatitis-C Incident Dendritic Cell Treatment Shows Promise for Decreasing Viral Loads in Chronic Hepatitis B: Presented at AAAAI Body's Own Hormone May Be Liver Disease's Worst Foe Vertex Broadens its Commitment to Improving HCV Care with Clinical Trial to Evaluate Combination Regimens Based on Oral Antiviral Therapies Needle Program Being Boosted in NSW Abbott and Enanta Announce Advancement of Hepatitis C Collaboration Enanta Nominates EDP-239 as Lead Development Candidate for NS5A HCV Inhibitor Program Targeted Delivery of Losartan Reduces Liver Inflammation and Scarring Hep C Sufferers Endangering Health to Get Treatment Hepatitis C for Fools Cops Escort Woman through Blizzard for Life-Saving Transplant Man With Hepatitis B Jailed for Sexual Assault Groundbreaking Research to Find Vaccine for Hepatitis C Acculis Breakthrough Liver Cancer Treatment Gets Green Light Major Bleeding Uncommon after Imaging-Guided Percutaneous Core Needle Biopsy Rock Stars Highlight Hepatitis C Risks Avail Clinical Research Announces Hepatitis C Research Studies in DeLand, FL Doctor in Hepatitis C Outbreak Declares Bankruptcy Board of Health Issues Tattoo Warning

http://www.hcvadvocate.org/news/newsRev/2010/NewsRev-351.html